Why Are High Level FDA Vaccine Regulators Resigning If The Vaccine Is Safe?

September 2, 2021 0 Comments

There has been a lot of skepticism over the COVID-19 vaccine and for good reason. It appears to be a rushed job and no one can really explain how any of it works at all. Then you couple that with the fact that even the top doctors are saying that the vaccine does not stop transmission of COVID or that it can even alleviate the symptoms of it.

So, why are they pushing everyone to take it?

If that is not enough to make anyone question the big push of this vaccine then there is the supposed FDA approval, but there is more to the story.

Shortly after the FDA gave the Pfizer jab the green light, there were some resignations that occurred in the FDA. Of course, resignations are not unheard of and it happens every day, but this is slightly different.

We are talking TWO two senior-level vaccine regulators have called it quits.

Now, we can sit here together and spitball all the reasons they left, right? Maybe these senior-level regulators resigned due to ethical issues with pushing mass vaccinations that clearly profits these companies making them. Or, maybe they had problems with the current administration’s booster policies and pushes for the public to get booster vaccines without adequate research.

What makes this incredibly interesting is that both of these regulators have been employees at the FDA for substantial periods of time, and it really begs the question, so why leave now?

The Epoch Times had more details:

According to a memo that was sent by Peter Marks, the head of FDA’s Center for Biologics Evaluation and Research (CBER) that oversees OVRR, and obtained by The Epoch Times, Gruber is leaving on Oct. 31. Krause is leaving sometime in November, the memo said.

Marks said in the memo that he would serve as the OVRR’s acting director while the FDA carries out a search for who should lead the division.

The memo did not provide a reason for why Gruber and Krause are leaving.

A LinkedIn profile for Gruber shows she worked for the FDA for 32 years and served as the OVRR’s director for about a decade. Krause, meanwhile, has worked for the FDA for about 11 years, according to his profile.

CNBC noted the two regulator’s frustration with The Biden Administration’s overreach on booster shots:

Endpoints News, a biotech industry publication, reported that the officials are leaving because they’re frustrated that the Centers for Disease Control and Prevention and its advisory committee are involved in decisions they think should be up to the FDA.

The final straw was when the White House got ahead of the agency on booster shots, according to Endpoints News, citing a former senior FDA leader.

When asked at a briefing later Tuesday whether the departures will affect trust in the FDA, White House Covid czar Jeff Zients said the decision to distribute boosters was made by a number of senior health officials, including acting FDA Commissioner Dr. Janet Woodcock. 

So what do you think?

Does this raise any red flags for you? Share your thoughts below!

 

 

Leave a Reply

Your email address will not be published. Required fields are marked *